Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Plasma ADMA as a biomarker to monitor PAH-targeted treatments

Nov. 16, 2012

Data presented on a novel EGFR inhibitor for patients with lung cancer

Nov. 16, 2012

PTC-596 shows efficacy in a number of tumor models in vivo

Nov. 16, 2012

Phase I trial of IMO-8400 begins, preclinical results presented

Nov. 16, 2012

Brodalumab does not demonstrate meaningful clinical efficacy in patients with RA

Nov. 15, 2012

Safety results presented from the AMETHYST-DN study

Nov. 15, 2012

MRC reports results of heterologus prime vaccination study at the ASTMH meeting in Atlanta

Nov. 14, 2012

Phase I results presented for the FMP-012 malaria vaccine

Nov. 14, 2012

Novel dual NADPH oxidase inhibitor shows excellent safety/pharmacokinetic profile

Nov. 14, 2012

sGPVI as a risk marker in inflammatory arthritis

Nov. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...